| New human data hints at psychedelics' potential to combat inflammation Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease. (Image credit: Cannabis-Pic) |
Read the rest of the story HERE:
At www.npr.org from NPR
At www.npr.org from NPR
